BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32495873)

  • 1. Diagnostic and prognostic significance of long noncoding RNA SSTR5-AS1 in patients with gastric cancer.
    Cheng Y; Di J; Wu J; Shi HT; Zou BC; Zhang Y; Xie DH
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5385-5390. PubMed ID: 32495873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High long non-coding LIFR-AS1 expression correlates with poor survival in gastric carcinoma.
    Wang HF; Lv JQ; Li HH; Wang W; Lin FQ
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5378-5384. PubMed ID: 32495872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased long non-coding RNA ARAP1-AS1 expression and its prognostic significance in human gastric cancer: a preliminary study.
    Jiang YH; Zhu XY; Guo ZY; Yang ZH
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1815-1820. PubMed ID: 32141550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
    Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
    Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
    Feng Y; Zhang Q; Wang J; Liu P
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway.
    Wu X; Zhang P; Zhu H; Li S; Chen X; Shi L
    Biomed Pharmacother; 2017 Dec; 96():1103-1108. PubMed ID: 29239821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Expression of Lncrna RP11-397A15.4 in Gastric Cancer and Its Clinical Significance.
    Chen H; Xu Z; Liu X; Gao Y; Wang J; Qian P; Yang B
    Ann Clin Lab Sci; 2018 Nov; 48(6):707-711. PubMed ID: 30610039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulatinglong non-coding RNA FEZF1-AS1 and AFAP1-AS1 serve as potential diagnostic biomarkers for gastric cancer.
    Liu W; Li Y; Zhang Y; Shen X; Su Z; Chen L; Cai W; Wang F; Ju S
    Pathol Res Pract; 2020 Jan; 216(1):152757. PubMed ID: 31785996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer.
    Yuan CL; Li H; Zhu L; Liu Z; Zhou J; Shu Y
    Neoplasma; 2016; 63(3):442-9. PubMed ID: 26925791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormally expressed long noncoding RNA B3GALT5-AS1 may serve as a biomarker for the diagnostic and prognostic of gastric cancer.
    Feng W; Zong W; Li Y; Shen X; Cui X; Ju S
    J Cell Biochem; 2020 Jan; 121(1):557-565. PubMed ID: 31338903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer.
    Dang Y; Lan F; Ouyang X; Wang K; Lin Y; Yu Y; Wang L; Wang Y; Huang Q
    World J Surg Oncol; 2015 Oct; 13():302. PubMed ID: 26472090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA CADM1-AS1 serves as a new prognostic biomarker for gastric cancer.
    Shi XY; Sun YZ; Li M; Li HY
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):232-238. PubMed ID: 31389606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of lncRNA VPS9D1-AS1 in gastric cancer and its clinical significance.
    Chen M; Wu X; Ma W; Zhou Q; Wang X; Zhang R; Wang J; Yang X
    Cancer Biomark; 2017 Dec; 21(1):23-28. PubMed ID: 29036784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic roles of long non-coding RNA SNHG17 in the patients with gastric cancer.
    Chen LL; He J; Qiu XT; Yu J; Wang ZM
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1063-1068. PubMed ID: 30779073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association of HOTAIR with the Diagnosis and Prognosis of Gastric Cancer and Its Effect on the Proliferation of Gastric Cancer Cells.
    Xu Z; Chen H; Yang B; Liu X; Zhou X; Kong H
    Can J Gastroenterol Hepatol; 2019; 2019():3076345. PubMed ID: 31281803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA microvascular invasion in hepatocellular carcinoma is an indicator of poor prognosis and a potential therapeutic target in gastric cancer.
    Wang A; Du L; Jiang K; Kong Q; Zhang X; Li L
    J Cancer Res Ther; 2019; 15(1):126-131. PubMed ID: 30880767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma.
    Wang B; Zhao L; Chi W; Cao H; Cui W; Meng W
    Epigenetics Chromatin; 2019 Jun; 12(1):35. PubMed ID: 31196171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer.
    Ke D; Li H; Zhang Y; An Y; Fu H; Fang X; Zheng X
    Oncotarget; 2017 Mar; 8(13):21516-21525. PubMed ID: 28423525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of long noncoding RNA LEF1-AS1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
    Zong MZ; Feng WT; Du N; Yu XJ; Yu WY
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7929-7934. PubMed ID: 31599448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.